Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia

Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders

(2018) Mohammad M. Khan   International Journal of Endocrinology

N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial

(2018) Paul Klauser et al.   Translational Psychiatry

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

(2017) Philippe Conus et al.   SCHIZOPHRENIA BULLETIN

Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry

(2017) L G Nucifora et al.   Translational Psychiatry

Methamphetamine Enhances the Development of Schizophrenia in First-Degree Relatives of Patients with Schizophrenia

(2017) Huabing Li et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Activation of G protein-coupled estrogen receptor 1 (GPER-1) ameliorates blood-brain barrier permeability after global cerebral ischemia in ovariectomized rats

(2016) Dan Lu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects

(2016) Alessandro Minarini et al.   Expert Opinion on Drug Metabolism & Toxicology

17β-Estradiol/N-acetylcysteine interaction enhances the neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency

(2016) K. Botsakis et al.   NEUROSCIENCE

Behaviour and prefrontal protein differences in C57BL/6N and 129 X1/SvJ mice

(2015) Xiaofan Zhang et al.   BRAIN RESEARCH BULLETIN

Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine

(2015) Vládia Célia Moreira Borella et al.   Developmental Neurobiology

Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

(2015) Kim Q. Do et al.   SCHIZOPHRENIA BULLETIN

Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice

(2015) Alice M. S. Durieux et al.   Frontiers in Behavioral Neuroscience

Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation

(2014) Sandra Giovanoli et al.   BRAIN BEHAVIOR AND IMMUNITY

Prenatal Exposure to the Viral Mimetic Poly I:C Alters Fetal Brain Cytokine Expression and Postnatal Behaviour

(2014) Udani Ratnayake et al.   DEVELOPMENTAL NEUROSCIENCE

The role of the hippocampus in flexible cognition and social behavior

(2014) Rachael D. Rubin et al.   Frontiers in Human Neuroscience

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress

(2014) Jelena Zlatković et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia

(2014) Hong Lin et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

(2014) Jan-Harry Cabungcal et al.   NEURON

Estrogen Receptors, the Hippocampus, and Memory

(2014) Linda A. Bean et al.   NEUROSCIENTIST

Sex differences in the adolescent developmental trajectory of parvalbumin interneurons in the hippocampus: A role for estradiol

(2014) YeeWen Candace Wu et al.   PSYCHONEUROENDOCRINOLOGY

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

(2014) Reza Bavarsad Shahripour et al.   Brain and Behavior

?7-Nicotinic Receptors and Cognition

(2013) Edward D. Levin   CURRENT DRUG TARGETS

Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species

(2013) Bridgette D. Semple et al.   PROGRESS IN NEUROBIOLOGY

Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine

(2013) Bruna Mara Machado Ribeiro et al.   SCHIZOPHRENIA RESEARCH

Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice

(2013) S. Giovanoli et al.   SCIENCE

Effects of an Alpha7 Nicotinic Receptor Agonist and Stress on Spatial Memory in an Animal Model of Alzheimer's Disease

(2013) Paloma Vicens et al.   Biomed Research International

N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia

(2012) Dikoma C. Shungu   BIOLOGICAL PSYCHIATRY

Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine

(2012) Jan-Harry Cabungcal et al.   BIOLOGICAL PSYCHIATRY

Sex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF

(2012) Y.C. Wu et al.   NEUROSCIENCE

Novel G Protein-Coupled Oestrogen Receptor GPR30 Shows Changes in mRNA Expression in the Rat Brain over the Oestrous Cycle

(2012) Emma J. Spary et al.   NEUROSIGNALS

Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial

(2012) Cristian Carmeli et al.   PLoS One

Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder

(2011) Anita Kulak et al.   BEHAVIOURAL BRAIN RESEARCH

Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor

(2011) Shui-Bing Liu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder

(2011) Olivia M. Dean et al.   NEUROSCIENCE LETTERS

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

(2011) David A. Lewis et al.   TRENDS IN NEUROSCIENCES

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The environment and schizophrenia

(2010) Jim van Os et al.   NATURE

Perseverative responding and neuroanatomical alterations in adult heterozygous reeler mice are mitigated by neonatal estrogen administration

(2010) Simone Macrì et al.   PSYCHONEUROENDOCRINOLOGY

Estrogen Promotes Parvalbumin Expression in Arcuate Nucleus POMC Neurons

(2010) Peter Sotonyi et al.   Reproductive Sciences

Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats

(2009) Stefania Schiavone et al.   BIOLOGICAL PSYCHIATRY

Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit

(2009) K. Radyushkin et al.   GENES BRAIN AND BEHAVIOR

Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI

(2009) Andrea Gogos et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia

(2009) Siok L. Dun et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

(2009) Jared W. Young et al.   PHARMACOLOGY & THERAPEUTICS

α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice

(2008) John P. Redrobe et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

LateN-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation

(2008) Fabien Lanté et al.   HIPPOCAMPUS

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

(2008) Felicity Ng et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL